DE69632898D1 - 3R-3'R Diastereoisomer von Zeaxanthin zur Behandlung von der Degeneration der Macula - Google Patents
3R-3'R Diastereoisomer von Zeaxanthin zur Behandlung von der Degeneration der MaculaInfo
- Publication number
- DE69632898D1 DE69632898D1 DE69632898T DE69632898T DE69632898D1 DE 69632898 D1 DE69632898 D1 DE 69632898D1 DE 69632898 T DE69632898 T DE 69632898T DE 69632898 T DE69632898 T DE 69632898T DE 69632898 D1 DE69632898 D1 DE 69632898D1
- Authority
- DE
- Germany
- Prior art keywords
- zeaxanthin
- macular degeneration
- cells
- stereoisomer
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US551153 | 1995-10-31 | ||
US550665 | 1995-10-31 | ||
US551166 | 1995-10-31 | ||
US08/551,153 US5827652A (en) | 1995-10-31 | 1995-10-31 | Zeaxanthin formulations for human ingestion |
US08/551,166 US5854015A (en) | 1995-10-31 | 1995-10-31 | Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion |
US08/550,665 US5747544A (en) | 1995-10-31 | 1995-10-31 | Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69632898D1 true DE69632898D1 (de) | 2004-08-19 |
DE69632898T2 DE69632898T2 (de) | 2005-08-04 |
Family
ID=27415594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69632898T Expired - Lifetime DE69632898T2 (de) | 1995-10-31 | 1996-10-31 | 3R-3'R Diastereoisomer von Zeaxanthin zur Behandlung von der Degeneration der Macula |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0774251B1 (de) |
AT (1) | ATE270882T1 (de) |
CA (1) | CA2188983C (de) |
DE (1) | DE69632898T2 (de) |
DK (1) | DK0774251T3 (de) |
ES (1) | ES2225863T3 (de) |
TW (1) | TW586930B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1010351C2 (nl) * | 1998-10-19 | 2001-01-08 | Werklust & Beheer B V | Esters van caroteno´den voor gebruik in de preventie en behandeling van oogaandoeningen. |
US20030228392A1 (en) | 2002-06-06 | 2003-12-11 | Wyeth | Infant formula compositions containing lutein and zeaxanthin |
US9192586B2 (en) | 2003-03-10 | 2015-11-24 | Zeavision Llc | Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders |
US20090118227A1 (en) | 2007-11-07 | 2009-05-07 | Bristol-Myers Squibb Company | Carotenoid-containing compositions and methods |
WO2011027209A1 (en) | 2009-09-02 | 2011-03-10 | Omniactive Health Technologies Ltd. | A xanthophyl composition containing macular pigments and a process for its preparation |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3891504A (en) | 1970-07-31 | 1975-06-24 | Hoffmann La Roche | Process for the manufacture of zeaxanthin |
BE790289A (fr) | 1971-10-27 | 1973-02-15 | Nestle Sa | Procede de fabrication de zeaxanthine |
CH572981A5 (de) | 1973-07-26 | 1976-02-27 | Nestle Sa | |
US4153615A (en) | 1978-03-27 | 1979-05-08 | Hoffmann-La Roche Inc. | Method of producing coloring agents |
DE3119383A1 (de) | 1981-05-15 | 1982-12-02 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinodpraeparaten |
US4737462A (en) | 1982-10-19 | 1988-04-12 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
KR920006865B1 (ko) | 1984-05-18 | 1992-08-21 | 워싱톤 유니버시티 테크놀러지 어소우시에이츠 인코오퍼레이티드 | 입자나 액적을 피복하는 방법과 장치 |
US4851339A (en) | 1986-04-01 | 1989-07-25 | Hills Christopher B | Extraction of anti-mutagenic pigments from algae and vegetables |
US5227507A (en) | 1987-03-27 | 1993-07-13 | Hoffmann-La Roche Inc. | Ethynylcyclohexene compounds and processes for manufacture thereof |
DK171297B1 (da) | 1987-03-27 | 1996-08-26 | Hoffmann La Roche | Fremgangsmåde til fremstilling af cyclohexenderivater som mellemprodukter til fremstilling af zeaxanthin samt cyclohexenderivater |
US5180747A (en) | 1989-02-28 | 1993-01-19 | Nisshin Flour Milling Co., Ltd. | Stabilized fat-soluble vitamin compositions |
EP0393690B1 (de) * | 1989-04-21 | 1995-03-29 | Kirin Beer Kabushiki Kaisha | Zur Synthese von Karotinoiden verwendbare DNA-Sequenzen |
US5429939A (en) | 1989-04-21 | 1995-07-04 | Kirin Beer Kabushiki Kaisha | DNA sequences useful for the synthesis of carotenoids |
US5290605A (en) * | 1989-06-29 | 1994-03-01 | Niva Shapira | Sun-exposure nutritional supporting composition |
DK0534955T3 (da) * | 1989-08-30 | 1997-10-13 | Applied Food Biotech Inc | Fremgangsmåde til fremstilling af en zeaxanthinholdig sammensætning under anvendelse af en mikroorganisme af arten Flavobacterium multivorum. |
DE4141351A1 (de) | 1991-12-14 | 1993-06-17 | Basf Ag | Stabile pulverfoermige vitamin- und/oder carotinoid-praeparate und verfahren zu deren herstellung |
DE4200728A1 (de) | 1992-01-14 | 1993-07-15 | Basf Ag | Stabile, fluessige praeparate fettloeslicher substanzen |
US5310764A (en) | 1992-05-08 | 1994-05-10 | Steven Baranowitz | Treatment of age related macular degeneration with beta-carotene |
US5382714A (en) | 1994-03-17 | 1995-01-17 | The Catholic University Of America | Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof |
DK0831797T3 (da) * | 1995-06-07 | 2007-04-02 | Howard Foundation | Farmaceutisk aktive carotenoider |
-
1996
- 1996-10-28 CA CA002188983A patent/CA2188983C/en not_active Expired - Lifetime
- 1996-10-31 ES ES96307928T patent/ES2225863T3/es not_active Expired - Lifetime
- 1996-10-31 AT AT96307928T patent/ATE270882T1/de not_active IP Right Cessation
- 1996-10-31 EP EP96307928A patent/EP0774251B1/de not_active Expired - Lifetime
- 1996-10-31 DE DE69632898T patent/DE69632898T2/de not_active Expired - Lifetime
- 1996-10-31 DK DK96307928T patent/DK0774251T3/da active
- 1996-11-28 TW TW085114674A patent/TW586930B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0774251B1 (de) | 2004-07-14 |
TW586930B (en) | 2004-05-11 |
ES2225863T3 (es) | 2005-03-16 |
EP0774251A2 (de) | 1997-05-21 |
ATE270882T1 (de) | 2004-07-15 |
DE69632898T2 (de) | 2005-08-04 |
CA2188983A1 (en) | 1997-05-01 |
DK0774251T3 (da) | 2004-11-22 |
EP0774251A3 (de) | 1997-06-18 |
CA2188983C (en) | 2001-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6586896A (en) | Fatty acid treatment | |
WO2004069190A3 (en) | Combination therapy for treating protein deficiency disorders | |
DE69636343D1 (de) | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen | |
DE69232485T2 (de) | VERWENDUNG VON RELAXIN zur Herstellung eines Arzneimittels für die Behandlung KARDIOVASKULÄREN Krankeiten. | |
KR940018089A (ko) | 내부조직의 방사선 손상에 대한 예방 및 처치방법 | |
EP0755633A1 (de) | Zwei-Phasen-Präparat | |
DE69632898D1 (de) | 3R-3'R Diastereoisomer von Zeaxanthin zur Behandlung von der Degeneration der Macula | |
MD1633B2 (en) | Application of lysozyme dimer and method of non-specific cellular and humoral stimulation of mechanisms for immune system protection and for prophylaxis and treatment of immunodepressant state or diseases relating to it | |
ATE192923T1 (de) | Verwendung von boswelliasäure zur behandlung von hirntumoren | |
Gordon | Elderly depressives: treatment and follow-up | |
DE69621786T2 (de) | Aminotetralinderivat zur behandlung von herzkreislauferkrankung | |
ATE110274T1 (de) | Mittel zur verbesserung spezifischer eigenschaften des blutes. | |
ATE283060T1 (de) | Verwendung einer pollenextrakt-haltigen verbindung zur behandlung hormon-assoziierter erkrankungen | |
HUP9902421A2 (hu) | Nyálkahártya-viszkozitást optimalizáló és bélfunkciót stimuláló hatású készítmények | |
AR004245A1 (es) | Tableta o capsula que contiene el estereoisómero 3r-3'r de zeaxantina y usos de dicho estereoisómero | |
DE602004031540D1 (de) | Zusammensetzung auf citicolin-basis in kombination mit vitaminen zur prävention und behandlung von augenerkrankungen | |
KR100749581B1 (ko) | 광합성 미생물을 함유한 호흡기 질환 치료제 | |
RU98110058A (ru) | Чистый 3r-3'r-стереоизомер зеаксантина для лечения дегенерации желтого пятна у людей | |
RU2053786C1 (ru) | Способ профилактики иммунодефицитных состояний | |
MX2022013214A (es) | Metodos para aumentar el flujo sanguineo microvascular. | |
UA10235A (uk) | Спосіб корекції дезадаптаційних розладів організму | |
AT13410U1 (de) | Verwendung einer Ubiquinon-Komponente und ein Kombinationspräparat zur Verbesserung der weiblichen Fertilität | |
UA31379A (uk) | Спосіб лікування ішемічної хвороби серця | |
Mertz | Risk Assessment for Essential Trace Elements in Humans | |
Simon | Weight-loss and sodium-reduction programmes reduced BP and the risk for hypertension in overweight adults with high-normal BP |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |